How much funding has Dermira raised?

Dermira has raised $202.0M in total funding, most recently a Venture Round.

Who are Dermira's investors?

Dermira's investors include Bay City Capital, Eli Lilly, Maruho Co., Ltd., Canaan Partners, NEA.

Where is Dermira headquartered?

Dermira is headquartered in Menlo Park, California, United States.

What industry is Dermira in?

Dermira operates in Biotech, Healthcare.

Dermira

Closed

Bringing biotech ingenuity to medical dermatology

Menlo Park, United States · Founded 2010 · $202.0M raised

Biotech

Healthcare

Headquarters: Menlo Park, California
Employees: 201–500
Founded: 2010
Business Model: B2B

Website: dermira.com
Total Funding: $202.0M
Last Round: $125.0M Venture RoundOct 2014
Rounds: 5

About

Dermira was a specialty biopharmaceutical company dedicated to developing differentiated therapies for chronic skin conditions. Based in Menlo Park, California, Dermira developed lebrikizumab (an IL-13 antibody for atopic dermatitis) and Qbrexza (for hyperhidrosis). The company was acquired by Eli Lilly for approximately $1.1 billion in 2020.

Summary

Dermira is a Biotech company based in Menlo Park, United States, founded in 2010. It has raised $202.0M in total across 5 rounds, most recently a $125.0M Venture Round round in Oct 2014. Investors include Bay City Capital, Eli Lilly and Maruho Co., Ltd..

LinkedIn X (Twitter)